SCHEMBL19652005

SCHEMBL19652005

CN1C(=O)C(=Cc2ccc(N(c3ccccc3)c3cccc4ccccc34)o2)C(=O)N(C)C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 12/20 0.48
MEN1 O00255 11/20 0.48
MAPT P10636 11/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 8/20 0.47
POLB P06746 5/20 0.47
NPC1 O15118 1/20 0.43
IDE P14735 1/20 0.43
HPGD P15428 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
MYC P01106 1/20 0.41
NPSR1 Q6W5P4 2/20 0.39
GFER P55789 1/20 0.39
PKM P14618 1/20 0.38
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.36
PLA2G1B P04054 1/20 0.36
DNMT1 P26358 1/20 0.36
PPARG P37231 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22108460 0.86 MEN1 (0.40) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL19652024 0.86 ESR2 (0.43) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL19658026 0.83 MAPT (0.40) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL19652008 0.82 MAPT (0.45) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL19652013 0.81 SIGMAR1 (0.34) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL19652021 0.78 MAPT (0.72) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL18882681 0.77 MEN1 (0.39) KMT2AMEN1MAPTRAB9AALDH1A1
SCHEMBL25870674 0.77 KMT2A (0.38) KMT2AMEN1MAPTRAB9AALDH1A1
SCHEMBL19652014 0.77 MAPT (0.41) KMT2AMEN1MAPTRAB9ASMN1; SMN2
SCHEMBL8204842 0.74 SIGMAR1 (0.44) KMT2AALDH1A1TDP1L3MBTL1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960362-B2 Compound and organic photoelectric device, image sensor and electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-01 US disclosed
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME Samsung Electronics Co .. Ltd. (KR) 2017-11-30 US disclosed
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME Samsung Electronics Co .. Ltd. (KR) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346016-A1 COMPOUND AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME PPOX, PIEZO1, CYP1A1 KMT2A 1370/4885MEN1 1455/4885MAPT 2370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.